Amaury Leruste

5PUBLICATIONS
72CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)HaematologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|Nov 01, 2024
Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads.

Julian Thalhammer, Eric Jeziorski, Perrine Marec-Bérard

|May 15, 2024
Engineered CD47 protects T cells for enhanced antitumour immunity.

Sean A Yamada-Hunter, Johanna Theruvath, Brianna J McIntosh

|Oct 20, 2020
Immune responses in genomically simple SWI/SNF-deficient cancers.

Amaury Leruste, Céline Chauvin, Celio Pouponnot

Pageof 1